67 results on '"Maiuri, Maria Chiara"'
Search Results
2. Comprehensive autophagy evaluation in cardiac disease models.
- Author
-
Kaludercic, Nina, Maiuri, Maria Chiara, Kaushik, Susmita, Fernández, Álvaro F, Bruijn, Jenny de, Castoldi, Francesca, Chen, Yun, Ito, Jumpei, Mukai, Risa, Murakawa, Tomokazu, Nah, Jihoon, Pietrocola, Federico, Saito, Toshiro, Sebti, Salwa, Semenzato, Martina, Tsansizi, Lorenza, Sciarretta, Sebastiano, and Madrigal-Matute, Julio
- Subjects
- *
HEART diseases , *PATHOLOGY - Abstract
Autophagy is a highly conserved recycling mechanism essential for maintaining cellular homeostasis. The pathophysiological role of autophagy has been explored since its discovery 50 years ago, but interest in autophagy has grown exponentially over the last years. Many researchers around the globe have found that autophagy is a critical pathway involved in the pathogenesis of cardiac diseases. Several groups have created novel and powerful tools for gaining deeper insights into the role of autophagy in the aetiology and development of pathologies affecting the heart. Here, we discuss how established and emerging methods to study autophagy can be used to unravel the precise function of this central recycling mechanism in the cardiac system. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
3. Cellular metabolism and diseases.
- Author
-
Maiuri, Maria Chiara and Maffia, Pasquale
- Subjects
- *
METABOLISM - Abstract
Linked Articles: This article is part of a themed issue on Cellular metabolism and diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.10/issuetoc. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
4. Macrophage Autophagy in Atherosclerosis.
- Author
-
Maiuri, Maria Chiara, Grassia, Gianluca, Platt, Andrew M., Carnuccio, Rosa, Ialenti, Armando, and Maffia, Pasquale
- Subjects
- *
MACROPHAGES , *AUTOPHAGY , *ATHEROSCLEROSIS , *IMMUNE response , *CYTOPLASM , *OXIDATIVE stress - Abstract
Macrophages play crucial roles in atherosclerotic immune responses. Recent investigation into macrophage autophagy (AP) in atherosclerosis has demonstrated a novel pathway through which these cells contribute to vascular inflammation. AP is a cellular catabolic process involving the delivery of cytoplasmic contents to the lysosomal machinery for ultimate degradation and recycling. Basal levels of macrophage AP play an essential role in atheroprotection during early atherosclerosis. However, AP becomes dysfunctional in the more advanced stages of the pathology and its deficiency promotes vascular inflammation, oxidative stress, and plaque necrosis. In this paper, we will discuss the role of macrophages and AP in atherosclerosis and the emerging evidence demonstrating the contribution of macrophage AP to vascular pathology. Finally, we will discuss how AP could be targeted for therapeutic utility. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
5. Autophagy regulation by p53
- Author
-
Maiuri, Maria Chiara, Galluzzi, Lorenzo, Morselli, Eugenia, Kepp, Oliver, Malik, Shoaib Ahmad, and Kroemer, Guido
- Subjects
- *
P53 protein , *REGULATION of cell metabolism , *CELLULAR signal transduction , *TUMOR suppressor proteins , *MITOCHONDRIA , *CELL death , *CELL cycle , *TRANSCRIPTION factors - Abstract
Autophagy is an evolutionarily conserved catabolic pathway that is involved in numerous physiological processes and in multiple pathological conditions including cancer. Autophagy is regulated by an intricate network of signaling cascades that have not yet been entirely disentangled. Accumulating evidence indicates that p53, the best-characterized human tumor suppressor protein, can modulate autophagy in a dual fashion, depending on its subcellular localization. On the one hand, p53 functions as a nuclear transcription factor and transactivates proapoptotic, cell cycle-arresting and proautophagic genes. On the other hand, cytoplasmic p53 can operate at mitochondria to promote cell death and can repress autophagy via poorly characterized mechanisms. This review focuses on the recently discovered function of p53 as a master regulator of autophagy. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
6. Stimulation of autophagy by the p53 target gene Sestrin2.
- Author
-
Maiuri, Maria Chiara, Malik, Shoaib Ahmad, Morselli, Eugenia, Kepp, Oliver, Criollo, Alfredo, Mouchel, Pierre-Luc, Carnuccio, Rosa, and Kroemer, Guido
- Published
- 2009
- Full Text
- View/download PDF
7. p53 represses autophagy in a cell cycle-dependent fashion.
- Author
-
Tasdemir, Ezgi, Maiuri, Maria Chiara, Orhon, Idil, Kepp, Oliver, Morselli, Eugenia, Criollo, Alfredo, and Kroemer, Guido
- Published
- 2008
- Full Text
- View/download PDF
8. Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-γ
- Author
-
De Stefano, Daniela, Maiuri, Maria Chiara, Simeon, Vittorio, Grassia, Gianluca, Soscia, Antonio, Cinelli, Maria Pia, and Carnuccio, Rosa
- Subjects
- *
LYCOPENE , *FATTY acids , *POLYPHENOLS , *MALABSORPTION syndromes - Abstract
Abstract: Oxidative stress plays an important role in inflammatory process of celiac disease. We have studied the effect of the lycopene, quercetin and tyrosol natural antioxidants on the inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) gene expression in RAW 264.7 macrophages stimulated by gliadin in association with IFN-γ. The IFN-γ plus gliadin combination treatment was capable of enhancing iNOS and COX-2 gene expression and nuclear factor-κB (NF-κB), interferon regulatory factor-1 (IRF-1) and signal transducer and activator of transcription-1α (STAT-1α) activation induced by reactive oxygen species generation at 24 h. Lycopene, quercetin and tyrosol inhibited all these effects. The results here reported suggest that these compounds may represent non toxic agents for the control of pro-inflammatory genes involved in celiac disease. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
9. Nuclear factor κB is activated in small intestinal mucosa of celiac patients.
- Author
-
Maiuri, Maria Chiara, De Stefano, Daniela, Mele, Guido, Fecarotta, Simona, Greco, Luigi, Troncone, Riccardo, and Carnuccio, Rosa
- Subjects
- *
TRANSCRIPTION factors , *CELIAC disease , *IMMUNE response , *CARRIER proteins , *CYCLOOXYGENASE 2 , *MOLECULAR biology - Abstract
NF-κB regulates inflammatory and immune response by increasing the expression of specific genes. In celiac disease proinflammatory cytokines, adhesion molecules, and enzymes whose gene expression is known to be regulated by NF-κB are involved. This study investigated the activation of NF-κB in inflamed mucosa from patients with untreated celiac disease. Biopsy specimens from control, untreated, and treated patients were subjected to molecular biology analysis. NF-κB activation was evaluated by electrophoretic mobility shift assay. NF-κB related subunit protein level, and inducible nitric oxide synthase and cyclo-oxygenase 2 protein expression was analyzed by western blot. Both NF-κB/DNA binding activity and p50/p65 nuclear levels were higher in biopsy specimens from untreated patients than in those from treated patients and controls. The degradation of IκBβ in the cytosol and the reappearance in the nucleus indicated a persistent NF-κB activation in celiac disease. NF-κB activity was maintained in cultured biopsy specimens up to 6 h and decreased at 24 h, and then the addition of peptic-tryptic digest of gliadin caused the recovery of NF-κB activity at 6 h. NF-κB/DNA binding activity was correlated with inducible nitric oxide synthase and cyclo-oxygenase-2 protein expression. These results show for the first time that NF-κB is activated in the inflamed mucosa of celiac patients and suggest that it may represent a molecular target for the modulation of inflammatory response in celiac disease. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
10. The life span-prolonging effect of sirtuin-1 is mediated by autophagy.
- Author
-
Morselli, Eugenia, Maiuri, Maria Chiara, Markaki, Maria, Megalou, Evgenia, Pasparaki, Angela, Palikaras, Konstantinos, Criollo, Alfredo, Galluzzi, Lorenzo, Malik, Shoaib Ahmad, Vitale, Ilio, Michaud, Mickael, Madeo, Frank, Tavernarakis, Nektarios, and Kroemer, Guido
- Published
- 2010
- Full Text
- View/download PDF
11. Serum metabolomic adaptations following a 12-week high-intensity interval training combined to citrulline supplementation in obese older adults.
- Author
-
Youssef, Layale, Durand, Sylvère, Aprahamian, Fanny, Lefevre, Deborah, Bourgin, Mélanie, Maiuri, Maria Chiara, Dulac, Maude, Hajj-Boutros, Guy, Marcangeli, Vincent, Buckinx, Fanny, Peyrusqué, Eva, Morais, José A., Gaudreau, Pierrette, Gouspillou, Gilles, Kroemer, Guido, Aubertin-Leheudre, Mylène, and Noirez, Philippe
- Subjects
- *
BLOOD serum analysis , *OBESITY treatment , *TRIGLYCERIDES , *LIPOPROTEINS , *METABOLOMICS , *LEPTIN , *ARGININE , *DIETARY supplements , *PHYSIOLOGICAL adaptation , *RANDOMIZED controlled trials , *PLACEBOS , *GAS chromatography , *BLIND experiment , *MASS spectrometry , *HIGH-intensity interval training , *AMINO acids , *COMBINED modality therapy , *STATISTICAL sampling , *ASPARTIC acid , *OLD age - Abstract
Physical activity and nutrition play important roles in preventing adverse health outcomes that accompany aging. It has been shown that high-intensity interval training (HIIT) combined with citrulline (CIT) supplementation can improve physical and functional capacities. The aim of this study was to evaluate serum metabolites following a 12-week HIIT combined or not with CIT in obese older adults, and to correlate the metabolic changes with clinico-biological parameters changes. Eighty-six obese older adults completed a 12-week HIIT program combined with a 10 g daily supplementation of either CIT or placebo (PLA) during a double-blinded randomized interventional trial. Only participants with blood samples at T0 (before the intervention) and/or T12 (after the intervention) were included in our sub-analysis (HIIT-PLA-T0: n = 44 and HIIT-PLA-T12: n = 28; HIIT-CIT-T0: n = 39 and HIIT-CIT-T12: n = 42). Serum samples were analyzed by different liquid or gas phase chromatography methods coupled to mass spectrometry. Among the identified metabolites, 44 changed significantly following the 12-week intervention (Time effect), and 10 of them were more affected when HIIT was combined with CIT (Time × Supp effect). Arginine increased significantly due to the 12-week intervention. Correlation analyses demonstrated that decreased triglyceride (TG) (16:1/18:1/16:0) and aspartic acid significantly correlated with a reduction of adiposity-related parameters (fat mass, leg lean mass, leptin, total triglycerides and low-density lipoprotein). Arginine, TG (16:1/18:1/16:0) and aspartic acid might constitute biomarkers of cardiometabolic health and adiposity. Further studies are needed to confirm these associations and understand the underlying mechanisms. Highlights A 12-week intervention involving high-intensity interval training (HIIT) with or without citrulline (CIT) supplementation induced adaptations in the serum metabolome of obese older adults through significant changes in 44 metabolites. Changes in 23 metabolites were observed when a CIT supplementation was administered along with a 12-week HIIT intervention. TG (16:1/18:1/16:0) correlated with several adiposity parameters including leptin, triglycerides, legs lean mass. Aspartic acid correlated with several adiposity parameters including leptin, LDL cholesterol as well as android, arms and trunk fat mass. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Crosstalk between apoptosis and autophagy within the Beclin 1 interactome.
- Author
-
Maiuri, Maria Chiara, Criollo, Alfredo, and Kroemer, Guido
- Subjects
- *
APOPTOSIS , *CELL death , *ENDOPLASMIC reticulum , *PHOSPHOINOSITIDES , *CELLULAR mechanics - Abstract
Although the essential genes for autophagy (Atg) have been identified, the molecular mechanisms through which Atg proteins control 'self eating' in mammalian cells remain elusive. Beclin 1 (Bec1), the mammalian orthologue of yeast Atg6, is part of the class III phosphatidylinositol 3-kinase (PI3K) complex that induces autophagy. The first among an increasing number of Bec1-interacting proteins that has been identified is the anti-apoptotic protein Bcl-2. The dissociation of Bec1 from Bcl-2 is essential for its autophagic activity, and Bcl-2 only inhibits autophagy when it is present in the endoplasmic reticulum (ER). A paper in this issue of the EMBO Journal has identified a novel protein, NAF-1 (nutrient-deprivation autophagy factor-1), that binds Bcl-2 at the ER. NAF-1 is a component of the inositol-1,4,5 trisphosphate (IP3) receptor complex, which contributes to the interaction of Bcl-2 with Bec1 and is required for Bcl-2 to functionally antagonize Bec1-mediated autophagy. This work provides mechanistic insights into how autophagy- and apoptosis-regulatory molecules crosstalk at the ER. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
13. Physiology to the Pleiotropic Role of RNAs: Prospecting Novel Therapies.
- Author
-
Maiuri, Maria Chiara, De Stefano, Daniela, and Farooqi, Ammad Ahmad
- Published
- 2014
- Full Text
- View/download PDF
14. Physiology to the Pleiotropic Role of RNAs: Prospecting Novel Therapies.
- Author
-
Maiuri, Maria Chiara, De Stefano, Daniela, and Farooqi, Ammad Ahmad
- Published
- 2014
- Full Text
- View/download PDF
15. Changes in Liver Lipidomic Profile in G2019S- LRRK2 Mouse Model of Parkinson's Disease.
- Author
-
Corral Nieto, Yaiza, Yakhine-Diop, Sokhna M. S., Moreno-Cruz, Paula, Manrique García, Laura, Gabrielly Pereira, Amanda, Morales-García, José A., Niso-Santano, Mireia, González-Polo, Rosa A., Uribe-Carretero, Elisabet, Durand, Sylvère, Maiuri, Maria Chiara, Paredes-Barquero, Marta, Alegre-Cortés, Eva, Canales-Cortés, Saray, López de Munain, Adolfo, Pérez-Tur, Jordi, Pérez-Castillo, Ana, Kroemer, Guido, Fuentes, José M., and Bravo-San Pedro, José M.
- Subjects
- *
PARKINSON'S disease , *DARDARIN , *LABORATORY mice , *ANIMAL disease models , *CARBOHYDRATE metabolism - Abstract
The identification of Parkinson's disease (PD) biomarkers has become a main goal for the diagnosis of this neurodegenerative disorder. PD has not only been intrinsically related to neurological problems, but also to a series of alterations in peripheral metabolism. The purpose of this study was to identify metabolic changes in the liver in mouse models of PD with the scope of finding new peripheral biomarkers for PD diagnosis. To achieve this goal, we used mass spectrometry technology to determine the complete metabolomic profile of liver and striatal tissue samples from WT mice, 6-hydroxydopamine-treated mice (idiopathic model) and mice affected by the G2019S-LRRK2 mutation in LRRK2/PARK8 gene (genetic model). This analysis revealed that the metabolism of carbohydrates, nucleotides and nucleosides was similarly altered in the liver from the two PD mouse models. However, long-chain fatty acids, phosphatidylcholine and other related lipid metabolites were only altered in hepatocytes from G2019S-LRRK2 mice. In summary, these results reveal specific differences, mainly in lipid metabolism, between idiopathic and genetic PD models in peripheral tissues and open up new possibilities to better understand the etiology of this neurological disorder. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. High plasma concentrations of acyl‐coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP.
- Author
-
Montégut, Léa, Joseph, Adrien, Chen, Hui, Abdellatif, Mahmoud, Ruckenstuhl, Christoph, Motiño, Omar, Lambertucci, Flavia, Anagnostopoulos, Gerasimos, Lachkar, Sylvie, Dichtinger, Silvia, Maiuri, Maria Chiara, Goldwasser, François, Blanchet, Benoit, Fumeron, Frédéric, Martins, Isabelle, Madeo, Frank, and Kroemer, Guido
- Subjects
- *
CARRIER proteins , *AGE , *MONOCLONAL antibodies , *CARDIOVASCULAR diseases , *SYSTOLIC blood pressure , *CARDIOVASCULAR diseases risk factors , *BODY mass index , *HIGH density lipoproteins - Abstract
Autophagy defects accelerate aging, while stimulation of autophagy decelerates aging. Acyl‐coenzyme A binding protein (ACBP), which is encoded by a diazepam‐binding inhibitor (DBI), acts as an extracellular feedback regulator of autophagy. As shown here, knockout of the gene coding for the yeast orthologue of ACBP/DBI (ACB1) improves chronological aging, and this effect is reversed by knockout of essential autophagy genes (ATG5, ATG7) but less so by knockout of an essential mitophagy gene (ATG32). In humans, ACBP/DBI levels independently correlate with body mass index (BMI) as well as with chronological age. In still‐healthy individuals, we find that high ACBP/DBI levels correlate with future cardiovascular events (such as heart surgery, myocardial infarction, and stroke), an association that is independent of BMI and chronological age, suggesting that ACBP/DBI is indeed a biomarker of "biological" aging. Concurringly, ACBP/DBI plasma concentrations correlate with established cardiovascular risk factors (fasting glucose levels, systolic blood pressure, total free cholesterol, triglycerides), but are inversely correlated with atheroprotective high‐density lipoprotein (HDL). In mice, neutralization of ACBP/DBI through a monoclonal antibody attenuates anthracycline‐induced cardiotoxicity, which is a model of accelerated heart aging. In conclusion, plasma elevation of ACBP/DBI constitutes a novel biomarker of chronological aging and facets of biological aging with a prognostic value in cardiovascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human Cancers.
- Author
-
De Palma, Fatima Domenica Elisa, Carbonnier, Vincent, Salvatore, Francesco, Kroemer, Guido, Pol, Jonathan G., and Maiuri, Maria Chiara
- Subjects
- *
RNA analysis , *TUMOR diagnosis , *STOMACH tumors , *OVARIAN tumors , *LUNG tumors , *BIOINFORMATICS , *GENE expression profiling , *KAPLAN-Meier estimator , *SURVIVAL analysis (Biometry) , *DESCRIPTIVE statistics , *TESTIS tumors , *TUMORS , *TUMOR markers , *RECEIVER operating characteristic curves , *EPIGENOMICS , *BREAST tumors ,TUMOR genetics - Abstract
Simple Summary: LINC01087 is a recently described long non-coding RNA. Its potential implication within oncology is being increasingly acknowledged. Here, we explored the clinical interest of LINC01087 in the diagnosis and prognostication of multiple cancer types. A series of in-depth in silico analyses revealed LINC01087 as a potential diagnostic indicator of some hormone-related tumors, including breast cancer (BC), ovarian carcinoma, and testicular germ cell tumors, as well as other cancer histotypes, such as esophageal and stomach cancers. Moreover, LINC01087 appears as a prognostic indicator in BC and renal papillary cell carcinoma. Therefore, the quantitation of LINC01087 in tissue specimens might have a clinical utility to improve the management of these pathologies in the future. (1) Background: Long non-coding RNAs may constitute epigenetic biomarkers for the diagnosis, prognosis, and therapeutic response of a variety of tumors. In this context, we aimed at assessing the diagnostic and prognostic value of the recently described long intergenic non-coding RNA 01087 (LINC01087) in human cancers. (2) Methods: We studied the expression of LINC01087 across 30 oncological indications by interrogating public resources. Data extracted from the TCGA and GTEx databases were exploited to plot receiver operating characteristic curves (ROC) and determine the diagnostic performance of LINC01087. Survival data from TCGA and KM-Plotter directories allowed us to graph Kaplan–Meier curves and evaluate the prognostic value of LINC01087. To investigate the function of LINC01087, gene ontology (GO) annotation and Kyoto Encyclopedia of Gene and Genomes (KEGG) enrichment analyses were performed. Furthermore, interactions between LINC01087 and both miRNA and mRNA were studied by means of bioinformatics tools. (3) Results: LINC01087 was significantly deregulated in 7 out of 30 cancers, showing a predominant upregulation. Notably, it was overexpressed in breast (BC), esophageal (ESCA), and ovarian (OV) cancers, as well as lung squamous cell carcinoma (LUSC), stomach adenocarcinoma (STAD), and uterine carcinosarcoma (UCS). By contrast, LINC01087 displayed downregulation in testicular germ cell tumors (TGCT). ROC curve analyses identified LINC01087 as a potential diagnostic indicator in BC, ESCA, OV, STAD, and TGCT. Moreover, high and low expression of LINC01087 predicted a favorable prognosis in BC and papillary cell carcinoma, respectively. In silico analyses indicated that deregulation of LINC01087 in cancer was associated with a modulation of genes related to ion channel, transporter, and peptide receptor activity. (4) Conclusions: the quantification of an altered abundance of LINC01087 in tissue specimens might be clinically useful for the diagnosis and prognosis of some hormone-related tumors, including BC, OV, and TGCT, as well as other cancer types such as ESCA and STAD. Moreover, our study revealed the potential of LINC01087 (and perhaps other lncRNAs) to regulate neuroactive molecules in cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis.
- Author
-
Motiño, Omar, Lambertucci, Flavia, Anagnostopoulos, Gerasimos, Sijing Li, Nah, Jihoon, Castoldi, Francesca, Senovilla, Laura, Montègut, Lèa, Hui Chen, Durand, Sylvère, Bourgin, Mèlanie, Aprahamian, Fanny, Nirmalathasan, Nitharsshini, Alvarez-Valadez, Karla, Sauvat, Allan, Carbonnier, Vincent, Djavaheri-Mergny, Mojgan, Pietrocola, Federico, Sadoshima, Junichi, and Maiuri, Maria Chiara
- Subjects
- *
CONCANAVALIN A , *HEPATIC fibrosis , *REPERFUSION injury , *FATTY acid oxidation , *PULMONARY fibrosis - Abstract
Acyl-coenzyme A (CoA)–binding protein (ACBP), also known as diazepam-binding inhibitor (DBI), is an extracellular feedback regulator of autophagy. Here, we report that injection of a monoclonal antibody neutralizing ACBP/DBI (α-DBI) protects the murine liver against ischemia/reperfusion damage, intoxication by acetaminophen and concanavalin A, and nonalcoholic steatohepatitis caused by methionine/cholinedeficient diet as well as against liver fibrosis induced by bile duct ligation or carbon tetrachloride. α-DBI downregulated proinflammatory and profibrotic genes and upregulated antioxidant defenses and fatty acid oxidation in the liver. The hepatoprotective effects of α-DBI were mimicked by the induction of ACBP/DBI-specific autoantibodies, an inducible Acbp/Dbi knockout or a constitutive Gabrg2F77I mutation that abolishes ACBP/DBI binding to the GABAA receptor. Liver-protective α-DBI effects were lost when autophagy was pharmacologically blocked or genetically inhibited by knockout of Atg4b. Of note, α-DBI also reduced myocardium infarction and lung fibrosis, supporting the contention that it mediates broad organ-protective effects against multiple insults. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histology.
- Author
-
Zeng, Qinghe, Klein, Christophe, Caruso, Stefano, Maille, Pascale, Laleh, Narmin Ghaffari, Sommacale, Daniele, Laurent, Alexis, Amaddeo, Giuliana, Gentien, David, Rapinat, Audrey, Regnault, Hélène, Charpy, Cécile, Nguyen, Cong Trung, Tournigand, Christophe, Brustia, Raffaele, Pawlotsky, Jean Michel, Kather, Jakob Nikolas, Maiuri, Maria Chiara, Loménie, Nicolas, and Calderaro, Julien
- Subjects
- *
HEPATOCELLULAR carcinoma , *ARTIFICIAL intelligence , *RECEIVER operating characteristic curves , *GENE expression profiling , *HISTOLOGY , *SURGICAL pathology - Abstract
Patients with hepatocellular carcinoma (HCC) displaying overexpression of immune gene signatures are likely to be more sensitive to immunotherapy, however, the use of such signatures in clinical settings remains challenging. We thus aimed, using artificial intelligence (AI) on whole-slide digital histological images, to develop models able to predict the activation of 6 immune gene signatures. AI models were trained and validated in 2 different series of patients with HCC treated by surgical resection. Gene expression was investigated using RNA sequencing or NanoString technology. Three deep learning approaches were investigated: patch-based, classic MIL and CLAM. Pathological reviewing of the most predictive tissue areas was performed for all gene signatures. The CLAM model showed the best overall performance in the discovery series. Its best-fold areas under the receiver operating characteristic curves (AUCs) for the prediction of tumors with upregulation of the immune gene signatures ranged from 0.78 to 0.91. The different models generalized well in the validation dataset with AUCs ranging from 0.81 to 0.92. Pathological analysis of highly predictive tissue areas showed enrichment in lymphocytes, plasma cells, and neutrophils. We have developed and validated AI-based pathology models able to predict the activation of several immune and inflammatory gene signatures. Our approach also provides insights into the morphological features that impact the model predictions. This proof-of-concept study shows that AI-based pathology could represent a novel type of biomarker that will ease the translation of our biological knowledge of HCC into clinical practice. Immune and inflammatory gene signatures may be associated with increased sensitivity to immunotherapy in patients with advanced hepatocellular carcinoma. In the present study, the use of artificial intelligence-based pathology enabled us to predict the activation of these signatures directly from histology. [Display omitted] • AI-based pathology can predict the activation of immune gene signatures directly from hepatocellular carcinoma histology. • Our models generalize well in an independent series of samples with different gene expression profiling technology and staining protocols. • These approaches could represent a novel type of biomarker. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Essential role for autophagy in life span extension.
- Author
-
Madeo, Frank, Zimmermann, Andreas, Maiuri, Maria Chiara, and Kroemer, Guido
- Subjects
- *
AUTOPHAGY , *LIFE spans , *LIFE expectancy , *LONGEVITY , *CYTOPLASM - Abstract
Life and health span can be prolonged by calorie limitation or by pharmacologic agents that mimic the effects of caloric restriction. Both starvation and the genetic inactivation of nutrient signaling converge on the induction of autophagy, a cytoplasmic recycling process that counteracts the age-associated accumulation of damaged organelles and proteins as it improves the metabolic fitness of cells. Here we review experimental findings indicating that inhibition of the major nutrient and growth-related signaling pathways as well as the upregulation of anti-aging pathways mediate life span extension via the induction of autophagy. Furthermore, we discuss mounting evidence suggesting that autophagy is not only necessary but, at least in some cases, also sufficient for increasing longevity. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. Autophagy Alteration in ApoA-I Related Systemic Amyloidosis.
- Author
-
Del Giudice, Rita, Imbimbo, Paola, Pietrocola, Federico, Martins, Isabelle, De Palma, Fatima Domenica Elisa, Bravo-San Pedro, José Manuel, Kroemer, Guido, Maiuri, Maria Chiara, and Monti, Daria Maria
- Subjects
- *
AMYLOIDOSIS , *APOLIPOPROTEIN A , *AUTOPHAGY , *AMINO acid sequence , *TRANSCRIPTION factors - Abstract
Amyloidoses are characterized by the accumulation and aggregation of misfolded proteins into fibrils in different organs, leading to cell death and consequent organ dysfunction. The specific substitution of Leu 75 for Pro in Apolipoprotein A-I protein sequence (ApoA-I; L75P-ApoA-I) results in late onset amyloidosis, where deposition of extracellular protein aggregates damages the normal functions of the liver. In this work, we describe that the autophagic process is inhibited in the presence of the L75P-ApoA-I amyloidogenic variant in stably transfected human hepatocyte carcinoma cells. The L75P-ApoA-I amyloidogenic variant alters the redox status of the cells, resulting into excessive mitochondrial stress and consequent cell death. Moreover, L75P-ApoA-I induces an impairment of the autophagic flux. Pharmacological induction of autophagy or transfection-enforced overexpression of the pro-autophagic transcription factor EB (TFEB) restores proficient proteostasis and reduces oxidative stress in these experimental settings, suggesting that pharmacological stimulation of autophagy could be a promising target to alleviate ApoA-I amyloidosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
22. Towards a rational combination therapy of cystic fibrosis.
- Author
-
Villella, Valeria R., Esposito, Speranza, Maiuri, Maria Chiara, Raia, Valeria, Kroemer, Guido, and Maiuri, Luigi
- Published
- 2013
- Full Text
- View/download PDF
23. Artificial intelligence for solid tumour diagnosis in digital pathology.
- Author
-
Klein, Christophe, Zeng, Qinghe, Arbaretaz, Floriane, Devêvre, Estelle, Calderaro, Julien, Lomenie, Nicolas, and Maiuri, Maria Chiara
- Subjects
- *
DIAGNOSIS , *ARTIFICIAL intelligence , *PATHOLOGY , *COMPUTER-assisted image analysis (Medicine) , *IMAGE analysis , *TUMOR diagnosis , *DIGITAL image processing , *ALGORITHMS - Abstract
Tumour diagnosis relies on the visual examination of histological slides by pathologists through a microscope eyepiece. Digital pathology, the digitalization of histological slides at high magnification with slides scanners, has raised the opportunity to extract quantitative information due to image analysis. In the last decade, medical image analysis has made exceptional progress due to the development of artificial intelligence (AI) algorithms. AI has been successfully used in the field of medical imaging and more recently in digital pathology. The feasibility and usefulness of AI assisted pathology tasks have been demonstrated in the very last years and we can expect those developments to be applied to routine histopathology in the future. In this review, we will describe and illustrate this technique and present the most recent applications in the field of tumour histopathology. LINKED ARTICLES: This article is part of a themed issue on Molecular imaging - visual themed issue. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.21/issuetoc. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Nanomaterials Toxicity and Cell Death Modalities.
- Author
-
De Stefano, Daniela, Carnuccio, Rosa, and Maiuri, Maria Chiara
- Subjects
- *
NANOSTRUCTURED materials , *TOXICITY testing , *CELL death , *NANOTECHNOLOGY , *PLETHORA (Pathology) , *IN vitro studies , *IN vivo toxicity testing - Abstract
In the last decade, the nanotechnology advancement has developed a plethora of novel and intriguing nanomaterial application in many sectors, including research and medicine. However, many risks have been highlighted in their use, particularly related to their unexpected toxicity in vitro and in vivo experimental models. This paper proposes an overview concerning the cell death modalities induced by the major nanomaterials. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
25. Oligonucleotide decoy to NF-κB slowly released from PLGA microspheres reduces chronic inflammation in rat
- Author
-
De Stefano, Daniela, De Rosa, Giuseppe, Maiuri, Maria Chiara, Ungaro, Francesca, Quaglia, Fabiana, Iuvone, Teresa, Cinelli, Maria Pia, La Rotonda, Maria Immacolata, and Carnuccio, Rosa
- Subjects
- *
AGGLOMERATION (Materials) , *CLUSTERING of particles , *COMPACTING , *ECONOMIC structure , *COAGULATION - Abstract
Abstract: Nuclear factor-κB (NF-κB) plays a key role in the expression of several genes involved in the immune and inflammatory process. Previously, we demonstrated that NF-κB activation can be significantly inhibited by a double stranded oligodeoxynucleotide (ODN). Nevertheless, the therapeutic use of ODN requires a delivery system able to improve poor crossing of cell membranes and rapid in vivo enzymatic degradation. Poly(d,l-lactide-co-glycolide) (PLGA) microspheres can increase ODN stability in biological environment and release the encapsulated drug in long time frames. Here, we used a decoy ODN against NF-κB and we investigated its effect, when administered in naked form or when delivered by PLGA micropsheres, in a rat model of chronic inflammation. The subcutaneous implant of λ-carrageenin-soaked sponges caused leukocyte infiltration and formation of granulation tissue which were inhibited up to 15 days by co-injection of microspheres releasing decoy ODN whereas naked decoy ODN showed this effect only up to 5 days. Molecular analysis performed on granulation tissue demonstrated an inhibition of NF-κB activation correlated to a decrease of tumor necrosis factor-α (TNF-α) and inducible nitric oxide synthase (iNOS) expression. Our results suggest that microspheres could be an useful tool to improve pharmacokinetics of decoy ODN and may represent a strategy to inhibit NF-κB activation in chronic inflammation. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
26. Mutant p53 protein localized in the cytoplasm inhibits autophagy.
- Author
-
Morselli, Eugenia, Tasdemir, Ezgi, Maiuri, Maria Chiara, Galluzzi, Lorenzo, Kepp, Oliver, Criollo, Alfredo, Vicencio, José Miguel, Soussi, Thierry, and Kroemer, Guido
- Published
- 2008
- Full Text
- View/download PDF
27. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement
- Author
-
Esposito, Giuseppe, De Filippis, Daniele, Maiuri, Maria Chiara, De Stefano, Daniela, Carnuccio, Rosa, and Iuvone, Teresa
- Subjects
- *
ALZHEIMER'S disease , *NEURONS , *MITOGEN-activated protein kinases , *ANTI-inflammatory agents - Abstract
Abstract: In view of the pro-inflammatory scenario observed in Alzheimer''s disease, in the recent years anti-inflammatory drugs have been proposed as potential therapeutic agents. We have previously shown that cannabidiol, the main non-psychotropic component from Cannabis sativa, possess a variegate combination of anti-oxidant and anti-apoptotic effects that protect PC12 cells from Aβ toxicity. In parallel, cannabidiol has been described to have anti-inflammatory properties in acute models of inflammation but the possible inhibitory effect of cannabidiol on iNOS protein expression and nitrite production in the nitrosative stress induced by Aβ in neuronal cell-line is un-investigated. Stimulation of differentiated PC12 cells with Aβ (1–42) (1μg/mL) for 36h caused a significant increase of nitrite production, compared to un-stimulated cells, that was inhibited in a concentration-dependent manner by both the non-selective iNOS inhibitor, l-NAME (0.3–30μM), and, at higher extent, by the selective iNOS inhibitor SMT (0.3–30μM). CBD (10−6 to 10−4 M) inhibited both nitrite production and iNOS protein expression induced by Aβ (1–42). Cannabidiol effect was mediated through the inhibition of phosphorylated form of p38 MAP kinase and transcription factor nuclear factor-κB activation in a concentration-dependent manner. The here reported data increases our knowledge about the possible neuroprotective mechanism of cannabidiol, highlighting the importance of this compound to inhibit β-amyloid induced neurodegeneration, in view of its low toxicity in humans. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
28. Caloric restriction mimetics for the treatment of cardiovascular diseases.
- Author
-
Sciarretta, Sebastiano, Forte, Maurizio, Castoldi, Francesca, Frati, Giacomo, Versaci, Francesco, Sadoshima, Junichi, Kroemer, Guido, and Maiuri, Maria Chiara
- Subjects
- *
LOW-calorie diet , *CARDIOVASCULAR diseases , *THERAPEUTICS , *CARDIOMYOPATHIES , *ANIMAL models for aging , *CARDIAC hypertrophy - Abstract
Caloric restriction mimetics (CRMs) are emerging as potential therapeutic agents for the treatment of cardiovascular diseases. CRMs include natural and synthetic compounds able to inhibit protein acetyltransferases, to interfere with acetyl coenzyme A biosynthesis, or to activate (de)acetyltransferase proteins. These modifications mimic the effects of caloric restriction, which is associated with the activation of autophagy. Previous evidence demonstrated the ability of CRMs to ameliorate cardiac function and reduce cardiac hypertrophy and maladaptive remodelling in animal models of ageing, mechanical overload, chronic myocardial ischaemia, and in genetic and metabolic cardiomyopathies. In addition, CRMs were found to reduce acute ischaemia–reperfusion injury. In many cases, these beneficial effects of CRMs appeared to be mediated by autophagy activation. In the present review, we discuss the relevant literature about the role of different CRMs in animal models of cardiac diseases, emphasizing the molecular mechanisms underlying the beneficial effects of these compounds and their potential future clinical application. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
29. Novel inducers of BECN1-independent autophagy: cis -unsaturated fatty acids.
- Author
-
Niso-Santano, Mireia, Bravo-San Pedro, José Manuel, Maiuri, Maria Chiara, Tavernarakis, Nektarios, Cecconi, Francesco, Madeo, Frank, Codogno, Patrice, Galluzzi, Lorenzo, and Kroemer, Guido
- Published
- 2015
- Full Text
- View/download PDF
30. Aspirin--another caloric-restriction mimetic.
- Author
-
Pietrocola, Federico, Castoldi, Francesca, Maiuri, Maria Chiara, and Kroemer, Guido
- Published
- 2018
- Full Text
- View/download PDF
31. Chitosan Gel to Treat Pressure Ulcers: A Clinical Pilot Study.
- Author
-
Campani, Virginia, Pagnozzi, Eliana, Mataro, Ilaria, Mayol, Laura, Perna, Alessandra, D’Urso, Floriana, Carillo, Antonietta, Cammarota, Maria, Maiuri, Maria Chiara, and De Rosa, Giuseppe
- Subjects
- *
BEDSORES treatment , *CHITOSAN , *PHARMACEUTICAL gels , *CHRONIC wounds & injuries , *WOUND healing , *THERAPEUTICS - Abstract
Chitosan is biopolymer with promising properties in wound healing. Chronic wounds represent a significant burden to both the patient and the medical system. Among chronic wounds, pressure ulcers are one of the most common types of complex wound. The efficacy and the tolerability of chitosan gel formulation, prepared into the hospital pharmacy, in the treatment of pressure ulcers of moderate severity were evaluated. The endpoint of this phase II study was the reduction of the area of the lesion by at least 20% after four weeks of treatment. Thus, 20 adult volunteers with pressure ulcers within predetermined parameters were involved in a 30 days study. Dressing change was performed twice a week at outpatient clinic upon chronic wounds management. In the 90% of patients involved in the study, the treatment was effective, with a reduction of the area of the lesion and wound healing progress. The study demonstrated the efficacy of the gel formulation for treatment of pressure ulcers, also providing a strong reduction of patient management costs. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
32. Metabolic interactions between cysteamine and epigallocatechin gallate.
- Author
-
Izzo, Valentina, Pietrocola, Federico, Sica, Valentina, Durand, Sylvère, Lachkar, Sylvie, Enot, David, Bravo-San Pedro, José Manuel, Chery, Alexis, Esposito, Speranza, Raia, Valeria, Maiuri, Luigi, Maiuri, Maria Chiara, and Kroemer, Guido
- Published
- 2017
- Full Text
- View/download PDF
33. Organelle-Specific Initiation of Autophagy.
- Author
-
Sica, Valentina, Galluzzi, Lorenzo, Bravo-San Pedro, José Manuel, Izzo, Valentina, Maiuri, Maria Chiara, and Kroemer, Guido
- Subjects
- *
AUTOPHAGY , *EUKARYOTIC cells , *HOMEOSTASIS , *ECOLOGICAL disturbances , *BIOLOGICAL adaptation , *CELL communication - Abstract
Autophagy constitutes a prominent mechanism through which eukaryotic cells preserve homeostasis in baseline conditions and in response to perturbations of the intracellular or extracellular microenvironment. Autophagic responses can be relatively non-selective or target a specific subcellular compartment. At least in part, this depends on the balance between the availability of autophagic substrates (“offer”) and the cellular need of autophagic products or functions for adaptation (“demand”). Irrespective of cargo specificity, adaptive autophagy relies on a panel of sensors that detect potentially dangerous cues and convert them into signals that are ultimately relayed to the autophagic machinery. Here, we summarize the molecular systems through which specific subcellular compartments—including the nucleus, mitochondria, plasma membrane, reticular apparatus, and cytosol—convert homeostatic perturbations into an increased offer of autophagic substrates or an accrued cellular demand for autophagic products or functions. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
34. Autophagy in malignant transformation and cancer progression.
- Author
-
Galluzzi, Lorenzo, Pietrocola, Federico, Bravo‐San Pedro, José Manuel, Amaravadi, Ravi K, Baehrecke, Eric H, Cecconi, Francesco, Codogno, Patrice, Debnath, Jayanta, Gewirtz, David A, Karantza, Vassiliki, Kimmelman, Alec, Kumar, Sharad, Levine, Beth, Maiuri, Maria Chiara, Martin, Seamus J, Penninger, Josef, Piacentini, Mauro, Rubinsztein, David C, Simon, Hans‐Uwe, and Simonsen, Anne
- Subjects
- *
AUTOPHAGY , *CANCER invasiveness , *HOMEOSTASIS , *CELL differentiation , *CANCER treatment , *CARCINOGENESIS - Abstract
Autophagy plays a key role in the maintenance of cellular homeostasis. In healthy cells, such a homeostatic activity constitutes a robust barrier against malignant transformation. Accordingly, many oncoproteins inhibit, and several oncosuppressor proteins promote, autophagy. Moreover, autophagy is required for optimal anticancer immunosurveillance. In neoplastic cells, however, autophagic responses constitute a means to cope with intracellular and environmental stress, thus favoring tumor progression. This implies that at least in some cases, oncogenesis proceeds along with a temporary inhibition of autophagy or a gain of molecular functions that antagonize its oncosuppressive activity. Here, we discuss the differential impact of autophagy on distinct phases of tumorigenesis and the implications of this concept for the use of autophagy modulators in cancer therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
35. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy.
- Author
-
Pedro, Jose Manuel Bravo-San, Wei, Yongjie, Sica, Valentina, Maiuri, Maria Chiara, Zou, Zhongju, Kroemer, Guido, and Levine, Beth
- Published
- 2015
- Full Text
- View/download PDF
36. Effect of hyaluronic acid on the thermogelation and biocompatibility of its blends with methyl cellulose.
- Author
-
Mayol, Laura, De Stefano, Daniela, De Falco, Francesca, Carnuccio, Rosa, Maiuri, Maria Chiara, and De Rosa, Giuseppe
- Subjects
- *
HYALURONIC acid , *BIOCOMPATIBILITY , *METHYLCELLULOSE , *MOLECULAR weights , *DRUG delivery systems - Abstract
Aim of this work was to investigate the influence of hyaluronic acid (HA) molecular weight on the thermogelation and biocompatibility of its blends with methyl cellulose in view of a possible application in drug delivery and/or wound healing.We found out that it was possible to obtain MC/HA blends showing a rheological behavior typical of a viscous solution at 20°C and of a weak gel at 37°C only when blending MC with low molecular weight HA. Moreover, the blends containing low molecular weight HA did not affect human foreskin fetal fibroblasts viability, proliferation and migration. On the contrary, the cell incubation with high molecular weight HA resulted in a marked and significant reduction of cell viability, compared to control cells. Finally, the optimized blends, in terms of rheological properties and biocompatibility, proved to be able to control and prolong bovine serum albumin release by a combined mechanism of platform dissolution and drug diffusion. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
37. Autophagy induction for the treatment of cancer.
- Author
-
Pietrocola, Federico, Pol, Jonathan, Vacchelli, Erika, Baracco, Elisa E., Levesque, Sarah, Castoldi, Francesca, Maiuri, Maria Chiara, Madeo, Frank, and Kroemer, Guido
- Published
- 2016
- Full Text
- View/download PDF
38. Synthesis and Pharmacological Evaluation of Modified Adenosines Joined to Mono-Functional Platinum Moieties.
- Author
-
D'Errico, Stefano, Oliviero, Giorgia, Borbone, Nicola, Piccialli, Vincenzo, Pinto, Brunella, De Falco, Francesca, Maiuri, Maria Chiara, Carnuccio, Rosa, Costantino, Valeria, Nici, Fabrizia, and Piccialli, Gennaro
- Subjects
- *
PHARMACOLOGY , *ADENOSINE synthesis , *MOIETIES (Chemistry) , *CISPLATIN , *ADENOCARCINOMA , *EPITHELIAL cells - Abstract
The synthesis of four novel platinum complexes, bearing N6-(6-aminohexyl) adenosine or a 1,6-di(adenosin-N6-yl)-hexane respectively, as ligands of monofunctional cisplatin or monochloro(ethylendiamine)platinum(II), is reported. The chemistry exploits the high affinity of the charged platinum centres towards the N7 position of the adenosine base system and a primary amine of an alkyl chain installed on the C6 position of the purine. The cytotoxic behaviour of the synthesized complexes has been studied in A549 adenocarcinomic human alveolar basal epithelial and MCF7 human breast adenocarcinomic cancer cell lines, in order to investigate their effects on cell viability and proliferation. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
39. Coffee induces autophagy in vivo.
- Author
-
Pietrocola, Federico, Malik, Shoaib Ahmad, Mariño, Guillermo, Vacchelli, Eerika, Senovilla, Laura, Chaba, Kariman, Niso-Santano, Mireia, Maiuri, Maria Chiara, Madeo, Frank, and Kroemer, Guido
- Published
- 2014
- Full Text
- View/download PDF
40. Regulation of autophagy by stress-responsive transcription factors.
- Author
-
Pietrocola, Federico, Izzo, Valentina, Niso-Santano, Mireia, Vacchelli, Erika, Galluzzi, Lorenzo, Maiuri, Maria Chiara, and Kroemer, Guido
- Subjects
- *
AUTOPHAGY , *TRANSCRIPTION factors , *CYTOPROTECTION , *HOMEOSTASIS , *ANTINEOPLASTIC agents , *AUTOIMMUNE diseases , *TUBEROUS sclerosis - Abstract
Abstract: Autophagy is an evolutionarily conserved process that promotes the lysosomal degradation of intracellular components including organelles and portions of the cytoplasm. Besides operating as a quality control mechanism in steady-state conditions, autophagy is upregulated in response to a variety of homeostatic perturbations. In this setting, autophagy mediates prominent cytoprotective effects as it sustains energetic homeostasis and contributes to the removal of cytotoxic stimuli, thus orchestrating a cell-wide, multipronged adaptive response to stress. In line with the critical role of autophagy in health and disease, defects in the autophagic machinery as well as in autophagy-regulatory signaling pathways have been associated with multiple human pathologies, including neurodegenerative disorders, autoimmune conditions and cancer. Accumulating evidence indicates that the autophagic response to stress may proceed in two phases. Thus, a rapid increase in the autophagic flux, which occurs within minutes or hours of exposure to stressful conditions and is entirely mediated by post-translational protein modifications, is generally followed by a delayed and protracted autophagic response that relies on the activation of specific transcriptional programs. Stress-responsive transcription factors including p53, NF-κB and STAT3 have recently been shown to play a major role in the regulation of both these phases of the autophagic response. Here, we will discuss the molecular mechanisms whereby autophagy is orchestrated by stress-responsive transcription factors. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
41. Cytoplasmic STAT3 Represses Autophagy by Inhibiting PKR Activity
- Author
-
Shen, Shensi, Niso-Santano, Mireia, Adjemian, Sandy, Takehara, Tetsuo, Malik, Shoaib Ahmad, Minoux, Hervé, Souquere, Sylvie, Mariño, Guillermo, Lachkar, Sylvie, Senovilla, Laura, Galluzzi, Lorenzo, Kepp, Oliver, Pierron, Gérard, Maiuri, Maria Chiara, Hikita, Hayato, Kroemer, Romano, and Kroemer, Guido
- Subjects
- *
CYTOPLASM , *AUTOPHAGY , *ENZYME inhibitors , *ENZYME activation , *GENE expression , *PHOSPHORYLATION , *GENE targeting , *PROTEIN-protein interactions - Abstract
Summary: In a screen designed to identify novel inducers of autophagy, we discovered that STAT3 inhibitors potently stimulate the autophagic flux. Accordingly, genetic inhibition of STAT3 stimulated autophagy in vitro and in vivo, while overexpression of STAT3 variants, encompassing wild-type, nonphosphorylatable, and extranuclear STAT3, inhibited starvation-induced autophagy. The SH2 domain of STAT3 was found to interact with the catalytic domain of the eIF2α kinase 2 EIF2AK2, best known as protein kinase R (PKR). Pharmacological and genetic inhibition of STAT3 stimulated the activating phosphorylation of PKR and consequent eIF2α hyperphosphorylation. Moreover, PKR depletion inhibited autophagy as initiated by chemical STAT3 inhibitors or free fatty acids like palmitate. STAT3-targeting chemicals and palmitate caused the disruption of inhibitory STAT3-PKR interactions, followed by PKR-dependent eIF2α phosphorylation, which facilitates autophagy induction. These results unravel an unsuspected mechanism of autophagy control that involves STAT3 and PKR as interacting partners. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
42. Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.
- Author
-
Luciani, Alessandro, Villella, Valeria Rachela, Esposito, Speranza, Gavina, Manuela, Russo, Ilaria, Silano, Marco, Guido, Stefano, Pettoello-Mantovani, Massimo, Carnuccio, Rosa, Scholte, Bob, De Matteis, Antonella, Maiuri, Maria Chiara, Raia, Valeria, Luini, Alberto, Kroemer, Guido, and Maiuri, Luigi
- Published
- 2012
- Full Text
- View/download PDF
43. Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins.
- Author
-
Pietrocola, Federico, Mariño, Guillermo, Lissa, Delphine, Vacchelli, Erika, Malik, Shoaib Ahmad, Niso.-Santano, Mireia, Zamzami, Naoufal, Galluzzi, Lorenzo, Maiuri, Maria Chiara, and Kroemer, Guido
- Published
- 2012
- Full Text
- View/download PDF
44. Cacospongionolide and Scalaradial, Two Marine Sesterterpenoids as Potent Apoptosis-Inducing Factors in Human Carcinoma Cell Lines.
- Author
-
De Stefano, Daniela, Tommonaro, Giuseppina, Malik, Shoaib Ahmad, Iodice, Carmine, De Rosa, Salvatore, Maiuri, Maria Chiara, and Carnuccio, Rosa
- Subjects
- *
CANCER cells , *APOPTOSIS , *CELL lines , *DNA , *DRUGS , *CELL proliferation - Abstract
Apoptosis, a form of programmed cell death, is a critical defence mechanism against the formation and progression of cancer and acts by eliminating potentially deleterious cells without causing such adverse effects, as inflammatory response and ensuing scar formation. Therefore, targeting apoptotic pathways becomes an intriguing strategy for the development of chemotherapeutic agents. In last decades, marine natural products, such as sesterterpenoids, have played an important role in the discovery and development of new drugs. Interestingly, many of these compounds have a strong potential as anticancer drugs by inhibiting cell proliferation and/or inducing cell death. In the present study, we investigated the effects of scalaradial and cacospongionolide, two sesterterpenoids from Cacospongia scalaris and Fasciospongia cavernosa marine sponges, on the apoptotic signalling pathway in three different human tumoral cells. Results were obtained by using DNA fragmentation, comet and viability assays, quantification of the mitochondrial transmembrane potential and Western blot. The T47D (human breast carcinoma), A431 (human epidermoid carcinoma), HeLa (human cervix carcinoma) and HCT116 (human colon carcinoma) cells were incubated for 24 h with scalaradial or cacospongionolide. Treatment of T47D cells with scalaradial or cacospongionolide for 24 h brought about a significant increase in DNA migration as well as fragmentation. Moreover, incubation of HCT116 and HeLa cells with scalaradial or cacospongionolide for 24 h caused an increased expression of pro-apoptotic proteins. Furthermore, scalaradial or cacospongionolide, added to HCT116 and HeLa cells overnight, induced a significant and concentration-dependent loss of mitochondrial transmembrane potential, an early apoptosis signalling event. These effects paralleled with those achieved with p50 and p65, NF-kB subunits, nuclear level. In conclusion, scalaradial and cacospongionolide, by determining human cancer cell apoptosis, may represent new promising compounds to inhibit cancer cell proliferation. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
45. Autophagy is required for the activation of NFκB.
- Author
-
Criollo, Alfredo, Chereau, Fanny, Malik, Shoaib Ahmad, Niso-Santano, Mireia, Mariño, Guillermo, Galluzzi, Lorenzo, Maiuri, Maria Chiara, Baud, Véronique, and Kroemer, Guido
- Published
- 2012
- Full Text
- View/download PDF
46. Inhibition of autophagy by TAB2 and TAB3.
- Author
-
Criollo, Alfredo, Niso-Santano, Mireia, Malik, Shoaib Ahmad, Michaud, Mickael, Morselli, Eugenia, Mariño, Guillermo, Lachkar, Sylvie, Arkhipenko, Alexander V, Harper, Francis, Pierron, Gérard, Rain, Jean-Christophe, Ninomiya-Tsuji, Jun, Fuentes, José M, Lavandero, Sergio, Galluzzi, Lorenzo, Maiuri, Maria Chiara, and Kroemer, Guido
- Subjects
- *
AUTOPHAGY , *NF-kappa B , *ENZYME activation , *PROTEIN kinases , *ENZYME inhibitors , *TRANSFORMING growth factors , *CELLULAR signal transduction - Abstract
Autophagic responses are coupled to the activation of the inhibitor of NF-?B kinase (IKK). Here, we report that the essential autophagy mediator Beclin 1 and TGF?-activated kinase 1 (TAK1)-binding proteins 2 and 3 (TAB2 and TAB3), two upstream activators of the TAK1-IKK signalling axis, constitutively interact with each other via their coiled-coil domains (CCDs). Upon autophagy induction, TAB2 and TAB3 dissociate from Beclin 1 and bind TAK1. Moreover, overexpression of TAB2 and TAB3 suppresses, while their depletion triggers, autophagy. The expression of the C-terminal domain of TAB2 or TAB3 or that of the CCD of Beclin 1 competitively disrupts the interaction between endogenous Beclin 1, TAB2 and TAB3, hence stimulating autophagy through a pathway that requires endogenous Beclin 1, TAK1 and IKK to be optimally efficient. These results point to the existence of an autophagy-stimulatory 'switch' whereby TAB2 and TAB3 abandon inhibitory interactions with Beclin 1 to engage in a stimulatory liaison with TAK1. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
47. Neuroendocrine regulation of autophagy by leptin.
- Author
-
Malik, Shoaib Ahmad, Mariño, Guillermo, BenYounes, Amena, Shen, Shensi, Harper, Francis, Maiuri, Maria Chiara, and Kroemer, Guido
- Published
- 2011
- Full Text
- View/download PDF
48. p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200.
- Author
-
Morselli, Eugenia, Shen, Shensi, Ruckenstuhl, Christoph, Bauer, Maria Anna, Mariño, Guillermo, Galluzzi, Lorenzo, Criollo, Alfredo, Michaud, Mickael, Maiuri, Maria Chiara, Chano, Tokuhiro, Madeo, Frank, and Kroemer, Guido
- Published
- 2011
- Full Text
- View/download PDF
49. A fluorescence-microscopic and cytofluorometric system for monitoring the turnover of the autophagic substrate p62/SQSTM1.
- Author
-
BenYounès, Amena, Tajeddine, Nicolas, Tailler, Maximilien, Malik, Shoaib Ahmad, Shen, Shensi, Métivier, Didier, Kepp, Oliver, Vitale, Ilio, Maiuri, Maria Chiara, and Kroemer, Guido
- Published
- 2011
- Full Text
- View/download PDF
50. Oncosuppressive Functions of Autophagy.
- Author
-
Morselli, Eugenia, Galluzzi, Lorenzo, Kepp, Oliver, Mariño, Guillermo, Michaud, Mickael, Vitale, Ilio, Maiuri, Maria Chiara, and Kroemer, Guido
- Subjects
- *
AUTOPHAGY , *CELL death , *HOMEOSTASIS , *ENDOPLASMIC reticulum , *INTRACELLULAR pathogens , *TUMOR suppressor proteins , *TUMOR proteins - Abstract
AbstractMacroautophagy (herein referred to as autophagy) constitutes a phylogenetically old mechanism leading to the lysosomal degradation of cytoplasmic structures. At baseline levels, autophagy exerts homeostatic functions by ensuring the turnover of potentially harmful organelles and long-lived aggregate-prone proteins. Moreover, the autophagic flow can be dramatically upregulated in response to a plethora of stressful conditions, including glucose, amino acid, oxygen, or growth factor deprivation, accumulation of unfolded proteins in the endoplasmic reticulum, and invasion by intracellular pathogens. In some experimental settings, stress-induced autophagy has been shown to contribute to programmed cell death. Nevertheless, autophagy most often confers cytoprotection by providing cells with new metabolic substrates or by ridding them of noxious intracellular entities including protein aggregates and invading organisms. Thus, autophagy has been implicated in an ever-increasing number of human diseases including cancer. Autophagy inhibition accelerates the demise of tumor cells that are subjected to chemo- or radiotherapy, thereby constituting an interesting target for the development of anticancer strategies. However, several oncosuppressor proteins and oncoproteins have been recently shown to stimulate and inhibit the autophagic flow, respectively, suggesting that autophagy exerts bona fidetumor-suppressive functions. In this review, we will discuss the mechanisms by which autophagy may prevent oncogenesis. Antioxid. Redox Signal.14, 2251–2269. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.